Meningitis Vaccine Urged After Teen Death

A recent meningitis death of a teenage boy in Oxfordshire has prompted a charity to strongly advocate for a wider rollout of the meningitis vaccine. Lewis Waters, a student at The Henley College, succumbed to the disease earlier this week. In connection with this case, two other pupils from Reading schools are undergoing treatment for meningitis. Meningitis Now, a leading charity, highlights the need to protect young lives, especially as MenB vaccinations are not currently part of the routine NHS immunisation schedule for teenagers and young adults. The Joint Committee on Vaccination and Immunisation (JCVI) is currently reviewing the eligibility criteria for the MenB vaccine. While the UK Health Security Agency confirmed one case as MenB and is awaiting test results for the others, the charity CEO noted that cost-effectiveness is often cited as a barrier to expanding the vaccine program. He stressed that the lives of young people are precious and that the vaccine has proven safe and effective in younger age groups. The UKHSA has identified a social network linking the affected individuals and is offering precautionary antibiotics to close contacts. While the risk to the general public is considered low, the charity urges vigilance as meningitis can affect anyone unexpectedly. Approximately 300 to 400 cases of meningococcal disease are diagnosed annually in England, predominantly affecting the young.